Hypertension, medications, and risk of severe COVID‐19: A Massachusetts community‐based observational study

It remains uncertain whether the hypertension (HT) medications angiotensin‐converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) mitigate or exacerbate SARS‐CoV‐2 infection. We evaluated the association of ACEi and ARB with severe coronavirus disease 19 (COVID‐19) as defined by...

Descripción completa

Detalles Bibliográficos
Autores principales: Bauer, Ann Z., Gore, Rebecca, Sama, Susan R., Rosiello, Richard, Garber, Lawrence, Sundaresan, Devi, McDonald, Anne, Arruda, Patricia, Kriebel, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Covid‐19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753489/
https://www.ncbi.nlm.nih.gov/pubmed/33220171
http://dx.doi.org/10.1111/jch.14101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753489/
https://www.ncbi.nlm.nih.gov/pubmed/33220171
http://dx.doi.org/10.1111/jch.14101

Ejemplares similares